| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |